alpha-aminopyridine has been researched along with Pneumonia in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keechilat, P; Kunoor, A; Pushpa Ragahavan, R; Rajendran, A | 1 |
| Neeland, MR; Ranganathan, S; Shanthikumar, S | 1 |
| Kawasaki, T; Kumagai, J; Miyazaki, Y; Okayasu, K | 1 |
| Arriola, E; Monzonís, X | 1 |
| Harwood, KH; Jarnicki, A; McQuade, RM; Schneider-Futschik, EK | 1 |
| Covel, J; Fierer, J; Kapoor, M; Okamoto, S; Shaw, KJ; Soltow, QA; Trzoss, M; Viriyakosol, S | 1 |
| Adamkov, M; Balentova, S; Calkovska, A; Kolomaznik, M; Kosutova, P; Mikolka, P; Mokra, D | 1 |
| Biller, H; Hohlfeld, JM; Holz, O; Janssen, O; Krug, N; Lavae-Mokhtari, B; Schaumann, F; Welker, L; Winkler, C | 1 |
| Etori, M; Goto, T; Hirahara, K; Maeda, H; Mikkaichi, T; Mizukami, K; Morimoto, K; Nakamura, S; Sogawa, Y; Suzuki, O; Takagi, N; Tsuchida, H; Yoshino, T | 1 |
| Becker, P; Greeff, O; Xaba, SN | 1 |
| Bury, A; Konrad, FM; Ngamsri, KC; Reutershan, J; Schick, MA | 1 |
| Eckle, T; Eltzschig, HK; Grenz, A; Laucher, S | 1 |
| Beume, R; Braun, A; Hoymann, HG; Korolewitz, R; Krug, N; Muller, M; Wollin, L | 1 |
| Bahra, P; Banner, KH; Dale, N; Freeman, MS; Hardaker, EL; Poll, C; Raza, F | 1 |
| Iwata, M; Kobayashi, M; Kubo, S; Ohtsu, Y; Shimizu, Y; Takahashi, K | 1 |
| Boulet, LP; Bredenbröker, D; Côté, J; Deschesnes, F; Duong, M; Gauvreau, GM; Killian, KJ; Milot, J; O'Byrne, PM; Schmid-Wirlitsch, C; Strinich, T; Watson, RM | 1 |
| Iwata, M; Kobayashi, M; Kubo, S; Miyata, K; Shimizu, Y; Takahashi, K | 1 |
| Konrad, FM; Reutershan, J; Stark, S; Vollmer, I; Witte, E | 1 |
| Vignola, AM | 1 |
| Beume, R; Bundschuh, DS; Marx, D; Wohlsen, A; Wollin, L | 1 |
2 review(s) available for alpha-aminopyridine and Pneumonia
| Article | Year |
|---|---|
Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.
Topics: Aminophenols; Aminopyridines; Anti-Inflammatory Agents; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Indoles; Inflammation; Ion Transport; Lung; Macrophages; Pneumonia; Quinolones; Signal Transduction | 2021 |
PDE4 inhibitors in COPD--a more selective approach to treatment.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Nitriles; Phosphodiesterase Inhibitors; Pneumonia; Pulmonary Disease, Chronic Obstructive; Rolipram; Theophylline; Treatment Outcome | 2004 |
2 trial(s) available for alpha-aminopyridine and Pneumonia
| Article | Year |
|---|---|
Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.
Topics: Administration, Inhalation; Adolescent; Adult; Aminopyridines; Benzamides; Cyclopropanes; Dose-Response Relationship, Drug; Drug Design; Endotoxins; Female; Healthy Volunteers; Humans; Lipopolysaccharides; Male; Middle Aged; Monocytes; Neutrophils; Phosphodiesterase 4 Inhibitors; Pneumonia; Reproducibility of Results; Research Design; Sputum; Young Adult | 2013 |
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.
Topics: Adolescent; Adult; Allergens; Aminopyridines; Asthma; Benzamides; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Pneumonia; Pulmonary Eosinophilia; Young Adult | 2011 |
16 other study(ies) available for alpha-aminopyridine and Pneumonia
| Article | Year |
|---|---|
Ribociclib-associated organising pneumonia.
Topics: Aminopyridines; Cough; Dyspnea; Humans; Middle Aged; Pneumonia; Purines | 2021 |
Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Mutation; Pneumonia; Quinolones | 2022 |
Clinicoradiological course of abemaciclib-induced pneumonitis with histology findings.
Topics: Aminopyridines; Chronic Disease; Female; Humans; Mucin-1; Neoplasm Recurrence, Local; Pneumonia | 2023 |
Early Onset Pulmonary Toxicity With Lorlatinib in a Patient With Previous Pulmonary Toxicity From Brigatinib.
Topics: Adenocarcinoma of Lung; Aminopyridines; Anaplastic Lymphoma Kinase; Female; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Middle Aged; Organophosphorus Compounds; Pneumonia; Prognosis; Pyrazoles; Pyrimidines | 2019 |
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Topics: Aminopyridines; Amphotericin B; Animals; Antifungal Agents; Coccidioides; Disease Models, Animal; Female; Fluconazole; Isoxazoles; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia; Prodrugs; Triazoles | 2019 |
Reduction of lung inflammation, oxidative stress and apoptosis by the PDE4 inhibitor roflumilast in experimental model of acute lung injury.
Topics: Acute Lung Injury; Aminopyridines; Animals; Apoptosis; Benzamides; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Female; Male; Oxidative Stress; Phosphodiesterase 4 Inhibitors; Pneumonia; Rabbits | 2018 |
Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice.
Topics: Administration, Ophthalmic; Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Gastric Emptying; Heterocyclic Compounds, 2-Ring; Humans; Leukocyte Disorders; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Neutrophils; Phenylacetates; Phosphodiesterase 4 Inhibitors; Pneumonia; Tumor Necrosis Factor-alpha | 2013 |
Determinants, outcomes and costs of ceftriaxone v. amoxicillin-clavulanate in the treatment of community-acquired pneumonia at Witbank Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Drug Combinations; Female; Humans; Length of Stay; Male; Middle Aged; Pneumonia; Sex Factors; Treatment Outcome | 2014 |
The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
Topics: Aminopyridines; Animals; Benzamides; Capillary Permeability; Chemokines; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cytoskeleton; Disease Models, Animal; Enzyme Activation; Epithelial Cells; Gene Expression; Male; Mice; Neutrophil Infiltration; Neutrophils; Phosphodiesterase 4 Inhibitors; Pneumonia; Protein Transport; Rolipram; Time Factors | 2015 |
A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; Chimera; Extravascular Lung Water; Female; Gene Expression Regulation; Lung Injury; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pneumonia; Pulmonary Alveoli; Receptor, Adenosine A2B; Receptors, Purinergic P1; Signal Transduction; Time Factors; Ventilators, Mechanical; Xanthines | 2008 |
Effects of the phosphodiesterase type 4 inhibitor roflumilast on early and late allergic response and airway hyperresponsiveness in Aspergillus-fumigatus-sensitized mice.
Topics: Aminopyridines; Animals; Antigens, Fungal; Aspergillus fumigatus; Asthma; Benzamides; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Eosinophils; Female; Leukocyte Count; Lymphocytes; Methacholine Chloride; Mice; Mice, Inbred BALB C; Neutrophils; Phosphodiesterase 4 Inhibitors; Pneumonia; Respiratory Hypersensitivity; Respiratory Mechanics | 2009 |
Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.
Topics: Adrenal Cortex Hormones; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Budesonide; Cyclopropanes; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Mucus; Neutrophil Infiltration; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pneumonia; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors; Tobacco Smoke Pollution | 2010 |
ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity.
Topics: Adrenergic alpha-2 Receptor Antagonists; Aminopyridines; Animals; Benzamides; Blood Cells; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Enzyme Inhibitors; Ferrets; Interleukin-4; Lipopolysaccharides; Macrophages, Alveolar; Naphthyridines; Nitriles; Pneumonia; Rats; Tumor Necrosis Factor-alpha; Vomiting | 2011 |
Anti-neutrophilic inflammatory activity of ASP3258, a novel phosphodiesterase type 4 inhibitor.
Topics: Adult; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Cells, Cultured; Chemokine CXCL1; Cyclohexanecarboxylic Acids; Cyclopropanes; Glucocorticoids; Humans; Lipopolysaccharides; Male; Naphthyridines; Neutrophils; Nitriles; Phosphodiesterase 4 Inhibitors; Pneumonia; Prednisolone; Rats; Rats, Wistar; Superoxides; Tumor Necrosis Factor-alpha | 2012 |
Adenosine receptor A2b on hematopoietic cells mediates LPS-induced migration of PMNs into the lung interstitium.
Topics: Acute Lung Injury; Adenosine A2 Receptor Agonists; Aminopyridines; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cell Count; Cells, Cultured; Chemokines; Cytoskeleton; Gene Expression; Gene Expression Regulation; Humans; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Pneumonia; Receptor, Adenosine A2B; Respiratory Burst; Transendothelial and Transepithelial Migration | 2012 |
Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Animals; Benzamides; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Immunization; Male; Neutrophils; Nitriles; Ovalbumin; Phosphodiesterase Inhibitors; Pneumonia; Pyridines; Rats; Respiratory Hypersensitivity; Rolipram; Serotonin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |